Substance P in serum and cerebrospinal fluid of depressed patients: No effect of antidepressant treatment

Psychiatry Research

Volumn 136, Issue 1, 2005, Pages 1-6

  Deuschle, Michael ^a   Sander, Peter ^a   Herpfer, Inga ^b   Fiebich, Bernd L ^b   Heuser, Isabella ^a,c   Lieb, Klaus ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Amitriptyline; Antidepressant; Course; Depressive disorder; Paroxetine; Treatment

Indexed keywords

AMITRIPTYLINE; PAROXETINE; SUBSTANCE P;

ADULT; AGE DISTRIBUTION; ARTICLE; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEX RATIO; TREATMENT OUTCOME;

ADULT; AGED; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; RECEPTORS, NEUROKININ-1; SEVERITY OF ILLNESS INDEX; SUBSTANCE P;

EID: 22744442604     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2004.12.007     Document Type: Article

References (23)

1. W.H. Berrettini, D.R. Rubinow, J.I. Nurnberger Jr., S. Simmons-Alling, R.M. Post, and E.S. Gershon CSF substance P immunoreactivity in affective disorders Biological Psychiatry 20 1985 965 970
2. B. Bondy, T.C. Baghai, C. Minov, C. Schule, M.J. Schwarz, P. Zwanzger, R. Rupprecht, and H.J. Möller Substance P serum levels are increased in major depression: preliminary results Biological Psychiatry 53 2003 538 542
3. M. Deuschle, B. Hamann, C. Meichel, B. Krumm, F. Lederbogen, A. Kniest, M. Colla, and I. Heuser Antidepressive treatment with amitriptyline or paroxetine: effects on saliva cortisol concentrations Journal of Clinical Psychopharmacology 23 2003 105 201
4. A.L. Freed, K.L. Audus, and S.M. Lunte Investigation of substance P transport across the blood-brain barrier Peptides 23 2002 157 165
5. P.G. Guyenet, and G.K. Aghajanian Excitation of neurons in the nucleus locus coeruleus by substance P and related peptides Brain Research 136 1977 178 184
6. N. Haddjeri, and P. Blier Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission Biological Psychiatry 50 2001 191 199
7. M.K. Hahn, and M.J. Bannon Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation Neuroscience 94 1999 1183 1188
8. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery and Psychiatry 23 1960 56 62
9. I. Herpfer, and K. Lieb Substance P and substance P receptor antagonists in the pathogenesis and treatment of affective disorders World Journal of Biological Psychiatry 4 2003 56 63
10. M.S. Kramer, N. Cutler, J. Feighner, R. Shrivastava, J. Carman, J.J. Sramek, S.A. Reines, G. Liu, D. Snavely, E. Wyatt-Knowles, J.J. Hale, S.G. Mills, M. MacCoss, C.J. Swain, T. Harrison, R.G. Hill, F. Hefti, E.M. Scolnick, M.A. Cascieri, G.G. Chicchi, S. Sadowski, A.R. Williams, L. Hewson, D. Smith, E.J. Carlson, R.J. Hargreaves, and N.M.J. Rupniak Distinct mechanism for antidepressant activity by blockade of central substance P receptors Science 281 1998 1640 1645
11. M.S Kramer, A. Winokur, J. Kelsey, S.H. Preskorn, A.J. Rothschild, D. Snavely, K. Ghosh, W.A. Ball, S.A. Reines, D. Munjack, J.T. Apter, L. Cunningham, M. Kling, M. Bari, A. Getson, and Y. Lee Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression Neuropsychopharmacology 29 2004 385 392
12. 3H]Nle11-Substance P Pharmazie 38 1983 108 110
13. K. Lieb, K. Ahlvers, K. Dancker, S. Strohbusch, M. Reincke, B. Feige, M. Berger, D. Riemann, and U. Voderholzer Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men Neuropsychopharmacology 27 2002 1041 1049
14. K. Lieb, J. Walden, H. Grunze, B.L. Fiebich, M. Berger, and C. Normann Serum levels of substance P and response to antidepressant pharmacotherapy Pharmacopsychiatry 37 2004 238 239
15. B. Martensson, S. Nyberg, G. Toresson, E. Brodin, and L. Bertilsson Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid Acta Psychiatrica Scandinavica 79 1989 586 596
16. G.P. McGregor, and S.R. Bloom Radioimmunoassay of substance P and its stability in tissue Life Sciences 32 1983 655 662
17. G.P. McGregor, and J.M. Conlon Regulatory peptide and serotonin content and brush-border enzyme activity in the rat gastrointestinal tract following neonatal treatment with capsaicin; lack of effect on epithelial markers Regulatory Peptides 32 1991 109 120
18. M. Otsuka, and K. Yoshioka Neurotransmitter functions of mammalian tachykinins Physiology Reviews 73 1993 229 308
19. R. Rimon, P. Le Greves, F. Nyberg, L. Heikkila, L. Salmela, and L. Terenius Elevation of substance P-like peptides in the CSF of psychiatric patients Biological Psychiatry 19 1984 509 516
20. N.M. Rupniak, and M.S. Kramer Discovery of the antidepressant and antiemetic efficacy of substance P receptor (NK 1) antagonists Trends in Pharmacological Sciences 20 1999 485 490
21. V. Sergeyev, T. Hokfelt, and Y. Hurd Serotonin and substance P co-exist in dorsal raphe neurons of the human brain NeuroReport 10 1999 3967 3970
22. Y. Shirayama, H. Mitsushio, M. Takashima, H. Ichikawa, and K. Takahashi Reduction of substance P after chronic antidepressant treatment in the striatum, substantia nigra and amygdala of the rat Brain Research 739 1996 70 78
23. 1 receptor antagonists as potential antidepressants Annual Review of Pharmacology and Toxicology 41 2001 877 906